Clinical trial Recruiting at 1 site Observational Ages 18 and up

Electrical Impedance Tomography for Monitoring Lung Disease

Official title: The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases

Run by University Hospital Olomouc · NCT07356076 · Data updated 2026-11-12

This test tries to see if a painless, noninvasive imaging method called electrical impedance tomography (EIT) can track how air is distributed in the lungs of adults with lung diseases and healthy volunteers and how those results match standard spirometry.

More Lung Diseases trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorUniversity Hospital Olomouc
Academic / other
Locations1 site (Olomouc)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJanuary 27, 2026
Trial IDNCT07356076 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with COPD, asthma, pulmonary fibrosis, pneumonia, or residual post-COVID lung findings, as well as healthy volunteers (non-smokers or ex-smokers) who can attend testing, are the ideal candidates.

Probably not a fit

People under 18, pregnant individuals, those with severe cardiovascular disease, or those unable to give informed consent are excluded and would not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will use Electrical Impedance Tomography (EIT) to record real-time, spatial patterns of lung ventilation in adults with a range of lung diseases and in healthy volunteers. Participants will undergo noninvasive EIT recordings alongside standard seated spirometry when possible, and a subgroup who cannot perform spirometry will be included to examine EIT utility without forced breathing. Investigators will compare EIT images with spirometry measures and normal reference data to identify ventilation patterns associated with different lung conditions. The work is conducted at the Department of Pulmonary Diseases and Tuberculosis, University Hospital Olomouc.

Why it matters

Potential benefit: If successful, EIT could provide a painless bedside way to detect and monitor regional lung problems, especially for patients who cannot perform spirometry.

How similar studies have gone: Prior research and clinical use of EIT in critical care and ventilation monitoring have shown promise, but using EIT broadly for routine outpatient lung diagnosis remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years and older
* Individuals diagnosed with any of the following lung diseases, as these are the primary focus of the study: Chronic obstructive pulmonary disease, Asthma, Pulmonary fibrosis, Pneumonia, Patients with a history of COVID-19 infection showing residual pulmonary findings.
* Additionally, healthy subjects will be enrolled to obtain normal standard values (with normal physical examination and no respiratory symptoms, BMI 18-36 - cause EIT performance can be BMI dependent, Non-smokers or ex-smokers abstinent ≥12 months)
* Ability to perform spirometry while seated, except for possible participants who are specifically part of a subgroup analysis where inability to perform spirometry is the condition which is studied.

Signing of an informed consent that has been approved by the ethics committee

Exclusion Criteria:

* Patients under 18 years of age
* Severe cardiovascular disease
* Pregnancy
* Inability to express consent
* Acute respiratory infection: Except for those recovering from pneumonia or COVID-19 within the study focus, participants with current respiratory infections will be excluded to avoid confounding effects on lung function tests
* Inability to perform spirometry

Where it's running

  • Department of Pulmonary Diseases and Tuberculosis, University hospital Olomouc
    Olomouc, Czechia
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.